CooperSurgical Inc has signed an agreement to acquire Teva Pharmaceutical Industries Ltd's PARAGARD (intrauterine copper contraceptive) for $1.1bn in cash.
The deal will enable CooperSurgical to repay term loan debt and reinforce its central nervous system (CNS) in addition to its respiratory business areas.
CooperSurgical is a medical and surgical products provider based in the US, while Teva is an Israeli pharmaceutical company.
Chinese firm Basecare Medical Device Co Ltd has secured CNY100m ($15.34m) in a series B funding round.
The company plans to use the funds towards the development of third-generation test-tube baby technology.
SPR Therapeutics LLC has secured $25m in a series C venture funding round led by a family office and Frontcourt Ventures.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe US-based company plans to use the funds towards the commercialisation of its FDA-cleared SPRINT peripheral nerve stimulation (PNS) system and additional research.
Cheetah Medical Inc has secured an additional $11.76m in a series C funding round, bringing the total funding to $40.61m. The company previously raised $14.4m in an extended series C financing round in February.
The US-based firm intends to use the stocks towards the expansion of its business in the country.